Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Segal

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The Spine Journal : Official Journal of the North American Spine Society|November 18, 2005
Nonvascular complications following spinal manipulationJeffrey S Oppenheim, Daniel E Spitzer, David H Segal
The Journal of Physiology|February 11, 2009
NDRG2, a novel regulator of myoblast proliferation, is regulated by anabolic and catabolic factorsVictoria C Foletta, Matthew J Prior, Nicole Stupka, et al.
Bioorganic & Medicinal Chemistry|September 10, 2015
Discovery and SAR of novel pyrazolo[1,5-a]pyrimidines as inhibitors of CDK9Louisa J Phillipson, David H Segal, Tracy L Nero, et al.
Blood|September 20, 2018
IMiDs prime myeloma cells for daratumumab-mediated cytotoxicity through loss of Ikaros and AiolosPasquale L Fedele, Simon N Willis, Yang Liao, et al.
Cell Death & Disease|September 11, 2020
Defining the susceptibility of colorectal cancers to BH3-mimetic compoundsMing-Jie Luo, Michelle Palmieri, Chris D Riffkin, et al.
Molecular Cell|May 19, 2023
PERIOD phosphorylation leads to feedback inhibition of CK1 activity to control circadian periodJonathan M Philpott, Alfred M Freeberg, Jiyoung Park, et al.
Metabolism: Clinical and Experimental|January 5, 2010
The characterization of Abelson helper integration site-1 in skeletal muscle and its links to the metabolic syndromeMatthew J Prior, Victoria C Foletta, Jeremy B Jowett, et al.
Physiological Genomics|November 18, 2010
A gene expression signature for insulin resistanceNicky Konstantopoulos, Victoria C Foletta, David H Segal, et al.
Blood|June 19, 2013
Targeting acute myeloid leukemia by dual inhibition of PI3K signaling and Cdk9-mediated Mcl-1 transcriptionDaniel Thomas, Jason A Powell, Francois Vergez, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The Spine Journal : Official Journal of the North American Spine Society|November 18, 2005
Nonvascular complications following spinal manipulationJeffrey S Oppenheim, Daniel E Spitzer, David H Segal
The Journal of Physiology|February 11, 2009
NDRG2, a novel regulator of myoblast proliferation, is regulated by anabolic and catabolic factorsVictoria C Foletta, Matthew J Prior, Nicole Stupka, et al.
Bioorganic & Medicinal Chemistry|September 10, 2015
Discovery and SAR of novel pyrazolo[1,5-a]pyrimidines as inhibitors of CDK9Louisa J Phillipson, David H Segal, Tracy L Nero, et al.
Blood|September 20, 2018
IMiDs prime myeloma cells for daratumumab-mediated cytotoxicity through loss of Ikaros and AiolosPasquale L Fedele, Simon N Willis, Yang Liao, et al.
Cell Death & Disease|September 11, 2020
Defining the susceptibility of colorectal cancers to BH3-mimetic compoundsMing-Jie Luo, Michelle Palmieri, Chris D Riffkin, et al.
Molecular Cell|May 19, 2023
PERIOD phosphorylation leads to feedback inhibition of CK1 activity to control circadian periodJonathan M Philpott, Alfred M Freeberg, Jiyoung Park, et al.
Metabolism: Clinical and Experimental|January 5, 2010
The characterization of Abelson helper integration site-1 in skeletal muscle and its links to the metabolic syndromeMatthew J Prior, Victoria C Foletta, Jeremy B Jowett, et al.
Physiological Genomics|November 18, 2010
A gene expression signature for insulin resistanceNicky Konstantopoulos, Victoria C Foletta, David H Segal, et al.
Blood|June 19, 2013
Targeting acute myeloid leukemia by dual inhibition of PI3K signaling and Cdk9-mediated Mcl-1 transcriptionDaniel Thomas, Jason A Powell, Francois Vergez, et al.
Pageof 1